Mixed News on Tough-to-Treat Lung Cancer
One drug made little difference, another showed promise in mice with genetic mutationContinue Reading
One drug made little difference, another showed promise in mice with genetic mutationContinue Reading
Patients taking memantine had more serious adverse events than those given placeboContinue Reading
Modest benefits might not outweigh bleeding risk, evidence review suggestsContinue Reading
Researchers say finding underscores real-world challenges facing those looking to quitContinue Reading
Older people with mild cognitive impairment saw improvements while using them, researchers reportContinue Reading
And married people showed greatest improvement afterwards, study foundContinue Reading
But other experts disagree, saying the best solution to hypertension is prompt drug therapyContinue Reading
Study showed more type 2 diabetes and high blood pressure as exposure roseContinue Reading
Research may hold hope for treating smoking-related lung diseases in humansContinue Reading
Disease management requires continuous coverage for preventive screenings, experts sayContinue Reading
Finding confirms what dog lovers already suspectedContinue Reading
This gap in survival is widest among those diagnosed with advanced disease, research showsContinue Reading
Debates over cellphone safety, cigarette-pack images also grabbed headlinesContinue Reading
Overuse of diagnostic exams can harm patient health, inflate medical costs, some experts warnContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.